- Home
- Life Sciences
- Biotechnology
- Biopharmaceutical
- Biopharmaceutical Analysis & Statistics, May 2013 (p2)
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Top countries
Publication dates
Publishers
- Global Data (191)
- Bioseeker (21)
- Euromonitor International (44)
- La Merie Publishing (38)
- Ibisworld (6)
-
- MarketLine (86)
- Asia Market Information & Development Company (7)
- Currentpartnering (4)
- Global Markets Direct (93)
- Canadean Ltd (11)
- Datamonitor (33)
- Global Research & Data Services (1)
- Infiniti Research Limited (6)
- MarketsandMarkets (3)
- World Market Intelligence Ltd (2)
- Business Monitor International (162)
- Life Science Analytics (LSA) (63)
- BCC Research (17)
- ICD Research (17)
- CCM International Limited (16)
- GBI Research (15)
- Freedonia (14)
- Frost & Sullivan (13)
- Visiongain (13)
- Global Industry Analyst (12)
- Espicom Business Intelligence (10)
- Business Review (9)
- BioPlan Associates, Inc. (8)
- Kalorama Information (7)
- Koncept Analytics (6)
- Research In China (6)
- CHI Insight Pharma Reports (4)
- IPEXL (4)
- International Market Analysis Research and Consult (4)
- Aruvian's R'search (3)
- BioPharm Reports (3)
- Pharmavision (3)
- RNCOS (3)
- SCRIP Insights (3)
- Venture Planning Group (3)
- Dolcera Corporation (2)
- Firstword Pharma (2)
- Arena (1)
- BioInformatics (1)
- Greystone Research Associates (1)
- Industry Experts (1)
- Plimsoll Publishing Ltd UK (1)
- SeeNews - Research & Profiles (1)
- The Centre for Food & Health Studies (1)
- Transparency Market Research (1)
- TriMark Publications (1)
- Urch Publishing (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
All regions
-
- Azerbaijan (1)
- Bahrain (1)
- China (53)
- Georgia (2)
- India (28)
- Indonesia (2)
- Iran (6)
- Israel (9)
- Japan (23)
- Jordan (1)
- Kazakhstan (5)
- Kuwait (1)
- Lebanon (5)
- Malaysia (5)
- Oman (4)
- Qatar (1)
- Saudi Arabia (2)
- Singapore (4)
- South Korea (10)
- Syrian Arab Republic (1)
- Taiwan (4)
- Thailand (2)
- Turkey (1)
- United Arab Emirates (1)
- Vietnam (2)
- Yemen (1)
-
- Austria (1)
- Belgium (11)
- Bulgaria (5)
- Croatia (5)
- Czech Republic (6)
- Denmark (5)
- Estonia (4)
- France (6)
- Germany (13)
- Greece (6)
- Hungary (5)
- Ireland (7)
- Italy (4)
- Latvia (4)
- Macedonia (1)
- Moldova, Republic Of (4)
- Netherlands (8)
- Norway (2)
- Poland (5)
- Romania (5)
- Russian Federation (7)
- Serbia and Montenegro (5)
- Slovakia (slovak Republic) (5)
- Slovenia (5)
- Spain (7)
- Sweden (3)
- Switzerland (12)
- Ukraine (5)
- United Kingdom (11)
-
- Australia (12)
- Austria (1)
- Belgium (11)
- Canada (27)
- Chile (5)
- Czech Republic (6)
- Denmark (5)
- Estonia (4)
- France (6)
- Germany (13)
- Greece (6)
- Hungary (5)
- Ireland (7)
- Israel (9)
- Italy (4)
- Japan (23)
- Mexico (7)
- Netherlands (8)
- New Zealand (3)
- Norway (2)
- Poland (5)
- Slovenia (5)
- South Korea (10)
- Spain (7)
- Sweden (3)
- Switzerland (12)
- Turkey (1)
- United Kingdom (11)
- United States (265)
data types
Free Market Research Guides to Download
Biopharmaceutical Analysis & Statistics, May 2013 (p2)
You might be interested in: biomedical, protein, antibody, more »
» Purchase Premium Reports
31-70 of about 800 reports
Global Vaccine Market
- $ 652
- Industry report
- May 2013
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in the world. The study provides essential market information for decision-makers ...
- Industries : Biopharmaceutical
- Countries : World
Muscling to the Top: Insights, Growth, and the Promise of Protein
- $ 400
- Industry report
- April 2013
- by Datamonitor
Introduction If you could design the perfect nutrient, it might look like protein. Not only is protein vital for health, but it has become a functional health star in packaged foods and drinks. This presentation ...
- Industries : Biopharmaceutical, Agricultural Products
- Countries : Greece
Competitor Analysis: Human Growth Hormone (hGH)
- $ 387
- Industry report
- April 2013
- by La Merie Publishing
Product description The Competitive Intelligence Report Human Growth Hormone (hGH) as of April 2013 provides a competitor analysis in the development pipeline of biosimilar versions of somatropin and next ...
- Industries : Biopharmaceutical
Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Biopharmaceutical
Navidea Biopharmaceuticals, Inc. (Formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Biopharmaceutical
Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Biopharmaceutical
Ondine Biomedical Inc. (OBP) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary This comprehensive SWOT profile of Ondine Biomedical Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to ...
- Industries : Biopharmaceutical
MP Biomedicals, LLC SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Nventa Biopharmaceuticals Corp. (NVN) - Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary This comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...
- Industries : Biopharmaceutical
Shin Nippon Biomedical Laboratories, Ltd. (Symbol:2395) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary This comprehensive SWOT profile of RegeneRx Biopharmaceuticals, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...
- Industries : Biopharmaceutical
Sun Biomedical Limited (Symbol:SBN) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Solco Biomedical Co., Ltd. (Symbol:043100) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
- Countries : United States
Sino Biopharmaceutical Limited (Symbol:1177) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
- Countries : China
STRATEC Biomedical Systems AG (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Nova Biomedical Corporation SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
BioMedical Technology Solutions Holdings, Inc. (Symbol:BMTL) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Amano Enzyme Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
- Countries : United States
Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Auricle Biomedical Corporation (AUB.P) - Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary This comprehensive SWOT profile of Auricle Biomedical Corporation provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...
- Industries : Biopharmaceutical
Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
- Countries : United States
BC Biomedical Laboratories Ltd. SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary This comprehensive SWOT profile of Kythera Biopharmaceuticals, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...
- Industries : Biopharmaceutical
XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Huifeng BioPharmaceutical Technology Inc. (Symbol:HFGB) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
Guatemala Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Guatemala
Croatia Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Croatia
Ireland Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Ireland
Egypt Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Egypt
India Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : India
Colombia Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Colombia
Argentina Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Argentina
Czech Republic Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Czech Republic
Canada Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Canada
Brazil Pharmaceutical Exports - Blood, Antisera, Vaccines, Toxins And Cultures, Us$mn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Biopharmaceutical
- Countries : Brazil
» Download Public Reports
About 1 700 reports
Import (harmonized System): Nucleic Acids And Their Salts, Other Heterocyclic Compounds
- Industry data
- April 2013
Monthly, From 2009 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics
Company Report: Vaccine In Canada For Year 2013
February 2013Enzyme Sector Analysis
March 2013U.s. Antibody Industry Brief
April 2013» Read our Company Profiles
24 CompaniesJohnson and Johnson
United StatesGlaxoSmithKline P.L.C.
United StatesBiogen Idec
United StatesNutrition Co.
United StatesAbbott Laboratories
United StatesReportlinker.com © Copyright 2013. All rights reserved.
